Actively Recruiting
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
Led by Chinese Pulmonary Vascular Disease Research Group · Updated on 2024-09-19
4000
Participants Needed
1
Research Sites
1044 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment
CONDITIONS
Official Title
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with pulmonary arterial hypertension (WHO Group 1)
- Diagnosed with chronic thromboembolic pulmonary hypertension
- Diagnosed with pulmonary arterial hypertension due to other causes
You will not qualify if you...
- Having massive hemoptysis
- Unable to complete cardiopulmonary exercise testing due to neuromuscular disorders
- Experiencing recent recurrent syncope
- Having pulmonary hypertension caused by hypoxia
- Having pulmonary hypertension caused by left heart diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
center of pulmonary vascular disease, Fuwai hospital
Beijing, China, 100037
Actively Recruiting
Research Team
Z
Zhihong Liu, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here